Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 4 Stomatitis 3 Neoplasm Metastasis 2 Head and Neck Neoplasms 2 Cancer Pain 2 Thromboembolism 1 Successful Conversion Rate of Operation 1 Sarcoma 1 Respiratory Insufficiency 1 Prostatic Neoplasms 1 Pneumonia 1 Pancreatic Neoplasms 1 Pain 1 Myocardial Infarction 1 Multiple Myeloma 1 Mucositis 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Kidney Diseases 1 Hematologic Neoplasms 1 Arrhythmias, Cardiac 1 Angina, Unstable 1 Adenocarcinoma 1 Acute Coronary Syndrome 1

Interventions

Docetaxel 292 Prednisone 240 enzalutamide 193 Leuprolide 185 Radiotherapy 179 Abiraterone Acetate 169 Magnetic Resonance Spectroscopy 163 bicalutamide 141 Goserelin 138 Androgen Antagonists 121 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108 Radiosurgery 108 apalutamide 92 gallium 68 PSMA-11 81 abiraterone 81 Specimen Handling 73 darolutamide 65 Surveys and Questionnaires 64 Gonadotropin-Releasing Hormone 63 Triptorelin Pamoate 58 Radiation 57 Biopsy 57 Brachytherapy 54 cabazitaxel 52 Standard of Care 51 Radiotherapy, Intensity-Modulated 51 Zoledronic Acid 50 pembrolizumab 49 luprolide acetate gel depot 49 Flutamide 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Sodium Bicarbonate × Clear all

NCT06661902 2026-02-17

BURN

University of Washington

Phase 1/2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡